TRABER PETER G 4
4 · SELECTA BIOSCIENCES INC · Filed Jan 4, 2023
Insider Transaction Report
Form 4
TRABER PETER G
Chief Medical Officer
Transactions
- Award
Common Stock
2023-01-02+200,000→ 457,765 total - Award
Employee Stock Option (right to buy)
2023-01-02+900,000→ 900,000 totalExercise: $1.13Exp: 2033-01-01→ Common Stock (900,000 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2024. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2027.
- [F2]Includes 6,410 shares of common stock purchased under the Issuer's Employee Stock Purchase Program during the contribution period between March 1, 2022 and August 31, 2022.
- [F3]This option vests as to 25% on January 2, 2024. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter.